Revolutionizing Neurodegenerative Disease Treatment via Brain-Penetrant Allosteric TYK2 inhibition
TicTwo is an early stage biotech developing best-in-class brain
penetrant TYK2 inhibitors targeting neurodegenerative diseases.
About TicTwo Therapeutics
Learn More
Our leadership team has decades of experience shaping strategy and innovation across the global pharmaceutical industry.
Our Science
Learn More